Back to Schedule
FinalSunday, May 3, 2026 · 7:30 PM
17 Wing68
Final
Team in the Lab67
Team Comparison
17 WingTeam in the Lab
Top Performers
#12 Reuben Francois-Saint-Cyr
17 Wing
21PTS
11REB
4AST
STL 4BLK 0FG 10-22 (45.5%)
#45 Dakota Martin
Team in the Lab
32PTS
12REB
0AST
STL 0BLK 0FG 14-24 (58.3%)
Box Score
17 Wing
| Player | MIN | PTS ▼ | REB | AST | STL | BLK | TOV | PF | FG | 3P | FT |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12Reuben Francois-Saint-Cyr | 0 | 21 | 11 | 4 | 4 | 0 | 2 | 3 | 10-22 | 1-6 | 0-1 |
| 8hans librando | 0 | 15 | 3 | 0 | 1 | 1 | 2 | 1 | 6-20 | 3-11 | 0-2 |
| 22Kelvin Lai | 0 | 10 | 1 | 1 | 2 | 0 | 2 | 1 | 3-10 | 2-6 | 2-5 |
| 77Tom Zaburdyaev | 0 | 7 | 8 | 1 | 0 | 0 | 1 | 0 | 3-6 | 1-4 | 0-0 |
| 7Anointing Nnah | 0 | 7 | 5 | 0 | 4 | 0 | 0 | 3 | 2-7 | 1-4 | 2-4 |
| 86Daniel Trommelen | 0 | 5 | 6 | 3 | 0 | 0 | 1 | 2 | 2-6 | 1-3 | 0-0 |
| 20Jordan Hutsal | 0 | 3 | 7 | 3 | 0 | 0 | 2 | 0 | 1-4 | 0-0 | 1-4 |
| 999Player #999 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0-0 | 0-0 | 0-0 |
| 5Andre Abarintos | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0-5 | 0-3 | 0-0 |
| TOTALS | 68 | 43 | 12 | 12 | 1 | 10 | 10 | 27-80 33.8% | 9-37 24.3% | 5-16 31.3% |
Team in the Lab
| Player | MIN | PTS ▼ | REB | AST | STL | BLK | TOV | PF | FG | 3P | FT |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 45Dakota Martin | 0 | 32 | 12 | 0 | 0 | 0 | 3 | 2 | 14-24 | 4-7 | 0-0 |
| 27Zechariah | 0 | 13 | 5 | 1 | 1 | 0 | 2 | 1 | 5-18 | 2-9 | 1-2 |
| 32Player #32 | 0 | 7 | 6 | 0 | 0 | 0 | 0 | 1 | 2-5 | 0-0 | 3-4 |
| 10Player #10 | 0 | 7 | 13 | 4 | 0 | 0 | 2 | 1 | 3-12 | 0-0 | 1-2 |
| 22Riley Versluis | 0 | 6 | 12 | 1 | 0 | 0 | 2 | 3 | 3-11 | 0-6 | 0-0 |
| 23Player #23 | 0 | 2 | 3 | 3 | 2 | 0 | 3 | 1 | 1-8 | 0-4 | 0-0 |
| 33Player #33 | 0 | 0 | 5 | 1 | 0 | 0 | 3 | 1 | 0-1 | 0-0 | 0-0 |
| 999Player #999 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0-0 | 0-0 | 0-0 |
| 9Player #9 | 0 | 0 | 2 | 1 | 0 | 0 | 3 | 0 | 0-0 | 0-0 | 0-0 |
| 4Player #4 | 0 | 0 | 4 | 1 | 0 | 0 | 2 | 0 | 0-2 | 0-1 | 0-0 |
| TOTALS | 67 | 63 | 12 | 3 | 0 | 20 | 10 | 28-81 34.6% | 6-27 22.2% | 5-8 62.5% |